Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.84 is in line with its 5-year average of 3.73, around the middle of its 5-year range (2.84–4.83).
As of the fiscal period ended Tuesday, June 30, 2026. 19.89% above its 12-month average of 3.20.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.84.
CURRENT RATIO
3.84
CURRENT RATIO AVG TTM
3.20
CURRENT RATIO AVG 3Y
3.60
CURRENT RATIO AVG 5Y
3.73
CURRENT RATIO AVG 10Y
4.14
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+19.89%
CURRENT VS 3Y AVG
+6.52%
CURRENT VS 5Y AVG
+3.01%
CURRENT VS 10Y AVG
-7.37%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 506 covered companies
CURRENT VS SECTOR MEDIAN
+14.38%
vs the sector median at left
Establishment Labs Holdings Inc.
Market Cap
$1.96B
Current Ratio
3.84
TTM Avg
3.20
3Y Avg
3.60
5Y Avg
3.73
Market Cap
$2.03B
Current Ratio
5.42
TTM Avg
4.91
3Y Avg
6.23
5Y Avg
8.44
Market Cap
$2.05B
Current Ratio
8.55
TTM Avg
6.61
3Y Avg
7.37
5Y Avg
8.17
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Establishment Labs Holdings Inc. (ESTA) | $1.96B | 3.84 | 3.20 | 3.60 | 3.73 |
| Absci Corporation (ABSI)vs › | $1.99B | 10.63 | 5.62 | 5.37 | 6.14 |
| Azenta, Inc. (AZTA)vs › | $2.01B | 2.50 | 3.53 | 6.11 | 4.96 |
| AxoGen, Inc. (AXGN)vs › | $2.00B | 6.60 | 4.18 | 3.84 | 4.49 |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | 0.96 | 0.99 | 1.34 | 1.34 |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.03B | 5.42 | 4.91 | 6.23 | 8.44 |
| Immunome, Inc. (IMNM)vs › | $2.02B | 15.08 | 9.38 | 7.12 | 8.07 |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 9.69 | 5.24 | 4.11 | 4.46 |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.05B | 8.55 | 6.61 | 7.37 | 8.17 |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.88B | 10.22 | 11.68 | 12.23 | 12.24 |
Current Ratio
3.84
Quick Ratio
2.52
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.84 |
| 2026-03-31 | 2.96 |
| 2025-12-31 | 3.04 |
| 2025-09-30 | 3.33 |
| 2025-06-30 | 2.84 |
| 2025-03-31 | 3.36 |
| 2024-12-31 | 3.56 |
| 2024-09-30 | 3.62 |
| 2024-06-30 | 4.44 |
| 2024-03-31 | 4.24 |
| 2023-12-31 | 3.06 |
| 2023-09-30 | 3.71 |
| 2023-06-30 | 4.83 |
| 2023-03-31 | 3.43 |
| 2022-12-31 | 3.85 |
| 2022-09-30 | 4.27 |
| 2022-06-30 | 4.50 |
| 2022-03-31 | 3.01 |
| 2021-12-31 | 3.55 |
| 2021-09-30 | 4.10 |
| 2021-06-30 | 4.70 |
| 2021-03-31 | 5.17 |
| 2020-12-31 | 5.11 |
| 2020-09-30 | 6.65 |
| 2020-06-30 | 6.64 |
| 2020-03-31 | 6.58 |
| 2019-12-31 | 4.12 |
| 2019-09-30 | 4.81 |
| 2019-06-30 | 3.94 |
| 2019-03-31 | 5.54 |
| 2018-12-31 | 6.05 |
| 2018-09-30 | 7.06 |
| 2018-06-30 | 2.42 |
| 2018-03-31 | 1.99 |
| 2017-12-31 | 0.69 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
